Key result
Genetically predicted high cathepsin E levels linked to ~6% higher osteoarthritis risk.
Why the study?
Cathepsin present in lysosomal cells may be closely related to bone, muscle and joint diseases, but its specific mechanism of action required further research and exploration.
Is there a causal relationship between genetically determined cathepsin levels and the risk of bone, muscle, and joint diseases?
Observational
Is there a causal relationship between genetically determined cathepsin levels and the risk of bone, muscle, and joint diseases?
Odds Ratio: 1.062864 (95% CI 1.0169496–1.110852)
p-value: p=0.006810154
Genetic evidence suggests specific cathepsins are causally associated with various bone, muscle, and joint diseases, highlighting potential new therapeutic targets.
MR evidence links cathepsins to BMJD risk; leaves open causality and any therapeutic implications for osteoporosis or osteoarthritis.
Objective: The cathepsin present in lysosomal cells may be closely related to bone, muscle & joint diseases (BMJD)including osteoporosis and osteoarthritis, but its specific mechanism of action still needs further research and exploration. The aim of this study is to use a two-sample Mendelian randomization (MR) comprehensive analysis to explore the causal relationship between cathepsin and the risk of BMJD. Method: Based on the published genetic data, this study used a two-sample Mendelian randomization (MR) comprehensive analysis method to explore the causality of morbidity risk between 9 cathepsins with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, peripheral arthritis(Crohn's disease, ulcerative colitis, and postdysentery joint disease), psoriatic joint disease, lower back pain, spinal stenosis, osteoporosis, bone necrosis, and connective tissue disease, cartilage diseases, benign tumors, myositis, synovitis and tenosynovitis (radial styloid tenosynovitis), shoulder periarthritis, neuromuscular junction diseases, and muscle atrophy. Meanwhile, in order to further reveal the possibility of reverse causality, we conducted a reverse Mendelian randomization analysis,using Cochran's Q test and MR Egger intercept test to evaluate the heterogeneity, horizontal pleiotropy,and stability of SNPs. Result: The study found that cathepsin B may be negatively correlated with ulcerative colitis arthritis, cathepsin E may be positively correlated with osteoarthritis, cathepsin E may be negatively correlated with musculoskeletal connective tissue diseases, cathepsin G may be positively correlated with ankylosing spondylitis, and cathepsin L2 may be positively correlated with cartilage diseases, Cathepsin S may be positively correlated with rheumatoid arthritis; through reverse MR analysis, we found that osteoporosis may lead to an increase in cathepsin B. In addition, we did not find any relationship between synovitis, tenosynovitis, shoulder periarthritis, bone necrosis, neuritis, osteoporosis,Crohn's arthritis,dysentery arthritis, psoriatic arthritis, low back pain,and cathepsin. Conclusion: Based on large-scale population studies of GWAS data, we conducted MR analysis and demonstrated a close relationship between cathepsins and BMJD from a genetic perspective, which may provide a basis for the pathogenesis of BMJD and provide new directions for future treatment strategies.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2024) conducted an observational in Bone, muscle & joint diseases (BMJD). Genetically predicted cathepsin levels vs. Unexposed/reference population was evaluated on Osteoarthritis (OR 1.062864, 95% CI 1.0169496-1.110852, p=0.006810154). Genetically predicted high levels of cathepsin E were positively correlated with an increased risk of osteoarthritis (OR 1.06).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: